CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
20th May 2016
A Cambridge company’s technology which can cut the diagnosis times for rare genetic diseases is being made available on the NHS.
Related News Articles
New report sets out roadmap to strengthen collaboration across the North’s health research ecosystem
A new report from the Northern Health Science Alliance (NHSA), commissioned and funded by the Academy of Medical Sciences, has identified practical steps to make it easier for researchers, clinicians, industry, policymakers and other partners to collaborate across the North of England.
Read the articlePHOTO GALLERY: A week in Amsterdam for HLTH 2026
View photos from a week in Amsterdam for HLTH 2026
Read the articleLandmark MRC-funded BEACON programme will support clinical academic careers across the North
Newcastle University, supported by the Northern Health Science Alliance, will lead a major new Medical Research Council (MRC) programme designed to strengthen clinical academic careers and research leadership across the North of England.
Read the article